सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

A 23-year-old man in the US became the first to be functionally cured of sickle cell disease using Casgevy, a CRISPR-based gene-editing therapy

GS3Economy · S&T · Environment · Security· Biotechnology & health research· Prelims + Mains·

Why in news

A 23-year-old man in the US became the first to be functionally cured of sickle cell disease using Casgevy, a CRISPR-based gene-editing therapy.

Background

Casgevy is a CRISPR-based therapy developed by Vertex Pharmaceuticals and CRISPR Therapeutics. It works by using a patient's own blood-forming stem cells to reactivate fetal haemoglobin production to prevent red blood cells from deforming.

Facts for Prelims

  • S&TCRISPR-Cas9: A tool for precise genome editing that allows scientists to 'cut' and 'paste' DNA sequences.
  • S&TCasgevy: The first CRISPR-based gene-editing therapy approved for sickle cell disease.
  • FactThe patient received edited cells in March 2026 and was discharged in April 2026 with normal haemoglobin levels.
  • S&TFetal Haemoglobin: A type of haemoglobin produced during fetal development that is normally silenced after birth.

For Mains

Q. Discuss the potential of CRISPR-based gene-editing technologies in revolutionizing the treatment of hereditary blood disorders and the ethical considerations surrounding human genome editing.

Dimensions to cover in your answer

  • Ethical dilemma: Balancing the potential for curative gene therapy against the risks of unintended off-target genetic mutations.
  • Accessibility gap: High cost of personalized CRISPR therapies creating a disparity in healthcare access for vulnerable populations.
  • Regulatory hurdle: Complexity in establishing safety protocols for permanent germline vs. somatic cell gene modifications.

Keywords: Gene Editing · CRISPR-Cas9 · Biotechnology · Hereditary Disorders · Precision Medicine

Read the full news →Source: Times of India ↗Also: GS2 · Health policy & public healthAlso: GS3 · Industry, investment & MSMEs

More Science & Technology notes

All Science & Technology current affairs →

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.